Site Search

Displaying results 321 - 330 of 519

RealHOPE

Real world handling of protein drugs - exploration, evaluation and education

PROTECT-trial

Proton versus photon therapy for esophageal cancer - a trimodality strategy

Ongoing IMI2 Cancer Conducting clinical trials

PERSIST-SEQ

Building a reproducible single-cell experimental workflow to capture tumour drug persistence

Ongoing IMI2 Cancer Disease taxonomy

UNITE4TB

Academia and industry united innovation and treatment for tuberculosis

Ongoing IMI2 Antimicrobial resistance Infectious diseases AMR Accelerator Clinical trial design Conducting clinical trials

HIPPOCRATES

Health initiatives in psoriasis and psoriatic arthritis consortium European states

Ongoing IMI2 Autoimmune diseases Skin diseases Biobanks Clinical networks Disease taxonomy Artificial intelligence

Alzheimer's Disease in the brain. Image courtesy of Doctor Jana. CC BY 4.0

11/06/2021

The most objective measure of your sociabilty? It’s in your pocket

PRISM is in talks with the EMA on the use of data from smartphones and wearables as biomarkers of social functioning in neuropsychiatric disorders.

PROMISE

Preparing for RSV immunisation and surveillance in Europe

Ongoing IMI2 Respiratory diseases Infectious diseases

PRISM 2

Psychiatric ratings using intermediate stratified markers 2

Ongoing IMI2 Neurodegenerative diseases Psychiatric diseases Alzheimer's disease Disease taxonomy Target identification

REsolution

Add medical genetic solutions to RESOLUTE (REsolution)

Closed IMI2 Tools for predicting/monitoring efficacy Disease taxonomy Target identification

Image courtesy of Orathai Mayoeh via shutterstock

01/06/2021

INNODIA diabetes findings prompt new research into other autoimmune diseases

Most research into autoimmune diseases focuses on the role of the immune system. But INNODIA research underscores the importance of studying the tissues under attack as well